Mingwen Li - Formosa Laboratories Director
| 4746 Stock | TWD 100.00 2.00 1.96% |
Director
Li Mingwen was serving as Director of FORMOSA LABORATORIES, INC. since March 27, 2014. Li also serves as Director in another company. Li holds a MBA from Temple University, the United States. since 2014.
| Tenure | 10 years |
| Professional Marks | MBA |
| Phone | 886 3 324 0895 |
| Web | https://www.formosalab.com |
Formosa Laboratories Management Efficiency
Formosa Laboratories' management efficiency ratios could be used to measure how well Formosa Laboratories manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Yida Li | Sinphar Pharmaceutical Co | N/A | |
| Shengbin Zeng | Grape King Bio | N/A | |
| Yonglu Cai | Apex Biotechnology Corp | N/A | |
| Shengyang Zeng | Grape King Bio | N/A | |
| ChingFu Chen | Grape King Bio | N/A | |
| YiMei Lou | Sinphar Pharmaceutical Co | N/A | |
| Boxiong Lai | Sinphar Pharmaceutical Co | N/A | |
| Zhengming Bai | Apex Biotechnology Corp | N/A | |
| YiTa Lee | Sinphar Pharmaceutical Co | N/A | |
| Yaoyuan Wen | Sinphar Pharmaceutical Co | N/A | |
| Mengwen Yang | Apex Biotechnology Corp | N/A | |
| Suhuan Wu | China Chemical Pharmaceutical | N/A | |
| ShengBin Tseng | Grape King Bio | N/A | |
| Jingzhong Cai | China Chemical Pharmaceutical | N/A | |
| Hongshou Chen | China Chemical Pharmaceutical | N/A | |
| Zhijia Zhang | Grape King Bio | N/A | |
| Fengyi Lin | Grape King Bio | N/A | |
| Xiuji Guo | Sinphar Pharmaceutical Co | N/A | |
| Yanyi Huang | Grape King Bio | N/A | |
| Yongdu Wei | Apex Biotechnology Corp | N/A | |
| Zongxiong Xu | Apex Biotechnology Corp | N/A | |
Management Performance
| Return On Equity | -0.0393 | |||
| Return On Asset | 0.0034 |
Formosa Laboratories Leadership Team
Elected by the shareholders, the Formosa Laboratories' board of directors comprises two types of representatives: Formosa Laboratories inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Formosa. The board's role is to monitor Formosa Laboratories' management team and ensure that shareholders' interests are well served. Formosa Laboratories' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Formosa Laboratories' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lujie Wang, Director | ||
| Shaohong Chen, Director | ||
| Yuzhen Luo, Deputy General Manager-Operations Support and Finance | ||
| ChenYu Cheng, Pres Chairman | ||
| Jianhong Li, Director | ||
| Jianmin Lin, Deputy General Manager-Project and Official Business | ||
| Mingwen Li, Director | ||
| Zhiping Yang, CEO | ||
| Jinnyuan Lin, Assistant Investment | ||
| Sifeng Chen, Director | ||
| Zhengyu Cheng, General Manager, Director | ||
| Chien Lin, VP Department | ||
| Zhaoshun Zhang, Independent Director | ||
| Zheren Zhuang, Independent Director | ||
| S BS, VP Sales | ||
| Qingpeng Wei, Deputy General Manager-Research and Development | ||
| ChaoShun Chang, Independent Director | ||
| Michelle Lo, VP Fin | ||
| Shanzhen Liu, Deputy General Manager-Business Division | ||
| Zhihan Zhong, Director | ||
| Dingkai Wu, Independent Director | ||
| Guangzong Li, Deputy General Manager-R&D Division | ||
| C Yang, Chief Officer |
Formosa Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Formosa Laboratories a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0393 | |||
| Return On Asset | 0.0034 | |||
| Profit Margin | (0.03) % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 9.7 B | |||
| Shares Outstanding | 120.26 M | |||
| Shares Owned By Insiders | 20.89 % | |||
| Shares Owned By Institutions | 4.64 % | |||
| Price To Earning | 97.70 X | |||
| Price To Book | 1.02 X |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Formosa Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Complementary Tools for Formosa Stock analysis
When running Formosa Laboratories' price analysis, check to measure Formosa Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Formosa Laboratories is operating at the current time. Most of Formosa Laboratories' value examination focuses on studying past and present price action to predict the probability of Formosa Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Formosa Laboratories' price. Additionally, you may evaluate how the addition of Formosa Laboratories to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |